| 标题 |
Phase 1b/2a randomized, double-blind study demonstrates potential of ABI-2280, a novel antiviral vaginal insert for the treatment of persistent high-risk/oncogenic HPV infection |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)